Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study

被引：0
|
作者：
Chao Xu
Xiaoli Xie
Ning Kang
Huiqing Jiang
机构：
[1] The Second Hospital of Hebei Medical University,Department of Gastroenterology
[2] Handan Central Hospital,Department of Gastroenterology
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Locally advanced gastric cancer; Apatinib; Programmed cell death protein 1 inhibitor; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4091 / 4099
页数：8
相关论文
共 50 条
  • [1] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Xu, Chao
    Xie, Xiaoli
    Kang, Ning
    Jiang, Huiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 4091 - 4099
  • [2] Short term efficacy and safety of PD-1 inhibitor and apatinib plus S-1 and oxaliplatin as neoadjuvant chemotherapy for patients with locally advanced gastric cancer
    Tang, Yunchuan
    Dai, Li
    Wang, Zhiqin
    Zhang, Meifeng
    Xie, Haitao
    Yang, Yunshan
    Zhou, Yongjin
    Yan, Zhiqiang
    Wang, Haibin
    Yang, Hongxin
    Zhang, Lei
    He, Tong
    Chen, Jiaju
    Wang, Guanghai
    Jin, Xiangren
    Wang, Qian
    MEDICINE, 2024, 103 (46) : e40572
  • [3] Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study
    Wang, Chunjing
    Wang, Zhen
    Zhao, Yue
    Wang, Fujing
    JOURNAL OF GASTRIC CANCER, 2023, 23 (02) : 328 - 339
  • [4] Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer
    Xiong, Hui
    Li, Yun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (08): : 3559 - 3570
  • [5] PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
    Wei, Qing
    Yuan, Xing
    Li, Jingjing
    Xu, Qi
    Ying, Jieer
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5315 - 5322
  • [6] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Sun, Yun
    Fan, Yanan
    Ye, Zhibin
    Dong, Jiantao
    Zhang, Lifei
    Peng, Yanhui
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1033 - 1040
  • [7] Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study
    Yun Sun
    Yanan Fan
    Zhibin Ye
    Jiantao Dong
    Lifei Zhang
    Yanhui Peng
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1033 - 1040
  • [8] The safety and efficacy of neoadjuvant PD-1 inhibitor plus chemotherapy for patients with locally advanced gastric cancer: a systematic review and meta-analysis
    Yu, Zhiyuan
    Liang, Chen
    Xu, Qixuan
    Yuan, Zhen
    Chen, Miao
    Li, Rui
    Zhou, Sixin
    Li, Peiyu
    Wei, Bo
    Zhao, Xudong
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1415 - 1426
  • [9] Comparison of Docetaxel plus Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis
    Zhang, Xin
    Huang, Hejing
    Wei, Ziran
    Zhu, Zhenxin
    Yang, Dejun
    Fu, Hongbing
    Xu, Jiapeng
    Hu, Zunqi
    Zhang, Yu
    You, Qing
    Huang, Xin
    Yan, Ronglin
    Wang, Weimin
    Cai, Qingping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 6641 - 6653
  • [10] Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma
    Zheng, Yanan
    Wang, Zhenqiang
    Yan, Chao
    Yan, Min
    Hou, Zhiguo
    Zheng, Rongrong
    Zhu, Zhenggang
    Li, Chen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
12345